Dana Farber Cancer Institute Reg. Ped — Boston, Massachusetts

Dana Farber Cancer Institute Reg. Ped is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute Reg. Ped has participated in 1 clinical trials.

Therapeutic areas: Hematologic Neoplasms.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute Reg. Ped?

Dana Farber Cancer Institute Reg. Ped has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute Reg. Ped conducted?

Dana Farber Cancer Institute Reg. Ped has 1 clinical trials on record. Their work covers Hematologic Neoplasms.

Is Dana Farber Cancer Institute Reg. Ped accredited by Crixeo Health?

Dana Farber Cancer Institute Reg. Ped has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute Reg. Ped?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.